The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage synthetic process. Early routes focused on protein portion coupling, utilizing solid-phase https://emiliegokd598692.ltfblog.com/39226975/production-and-research-implementations-of-retatrutide